胰腺癌中医证型分析标
Traditional Chinese Medicine Syndrome Type Analysis of Pancreatic Cancer

作者: 张琨 :上海中医药大学,上海; 寿伟臻 :上海中医药大学附属龙华医院,上海;

关键词: 胰腺癌中医证型分析Pancreatic Cancer The Doctor of Traditional Chinese Medicine The Type of Analysis

摘要: 目的:探讨胰腺癌中医证型出现状况的内在规律,加深目前中医对食管癌不同证型的认识,寻找其规律。方法:统计分析1979年以来国内公开报道的有关胰腺癌中医证型分型的文献,数据应用Frequencie法和卡方检验对收集到的文献和病例资料进行讨论。结果:按照入选标准和排除标准,共纳入29篇论文,分析结果显示胰腺癌常见证型有6种,分别为湿热毒邪、气滞血瘀、脾虚湿热、脾虚、气血两虚、脾虚气滞。胰腺癌证型以实证多见,湿热毒邪与气质血瘀是胰腺癌最常见的证型。其次是虚实夹杂与虚证,二者均多以脾虚为本,在脾虚基础上伴有湿热,气滞,血瘀等标实表现。结论:目前对胰腺癌中医证候的证型研究尚属于探索阶段,仍需展开大样本的中医证候调查以提高证据的可靠性与科学性。

Abstract: Objective: To explore the inherent law of TCM syndrome types emerge, pancreatic cancer, deepen the understanding of different syndrome types of traditional Chinese medicine, to find the rule. Methods: Statistical analysis since 1979 domestic publicly reported in the literature of TCM syn-drome classification of pancreatic cancer, data Frequencie method and chi-square test were applied to the collected literature and case materials were discussed. Results: According to the inclusion criteria and exclusion criteria included in the paper, the analysis results indicated that pancreatic cancer often witness had 6 kinds, respectively, damp heat toxin factor, qi and blood stasis, humid pixu (spleen deficient), pixu (spleen deficient), two qi, and qi stagnation pixu (spleen deficient). Pancreatic cancer syndrome in empirical, damp heat toxin factor and temperament and blood stasis is the most common pancreatic cancer evidence type. Second is factors and deficiency syndrome, both based on pixu (spleen deficient), on the basis of spleen deficiency with damp heat, qi stagnation, blood stasis and other standard performance. Conclusions: The present research on justification of TCM syndrome type of pancreatic cancer still belongs to the exploration stage and still needs a large sample of TCM syndrome investigation in order to improve the reliability of the evidence and the scientific nature.

文章引用: 张琨 , 寿伟臻 (2016) 胰腺癌中医证型分析标。 医学诊断, 6, 10-14. doi: 10.12677/MD.2016.61003

参考文献

[1] Long, J., Luo, G.P., Xiao, Z.W., et al. (2014) Cancer Statistics: Current Diagnosis and Treatment of Pancreatic Cancer in Shanghai, China. Cancer Letters, 346, 273-277.
http://dx.doi.org/10.1016/j.canlet.2014.01.004

[2] Siegel, R., Ma, J., Zou, Z., et al. (2014) Cancer Statistics. CA: A Cancer Journal for Clinicians, 64, 9-29.
http://dx.doi.org/10.3322/caac.21208

[3] Guo, X. and Cui, Z. (2005) Current Diagnosis and Treatment of Pancreatic Cancer in China. Pancreas, 31, 13-22.
http://dx.doi.org/10.1097/01.mpa.0000168220.97967.d1

[4] 王天芳. 中医诊断学[M]. 北京: 中国医药科技, 2012: 193.

[5] 陈宏丽, 黄淑芳, 赵永烈. 胰腺癌诊治病案1则[J]. 北京中医药大学学报: 中医临床版, 2011, 18(5): 13-15.

[6] 陈创, 王永军. 中西医结合治疗中晚期胰腺癌42例[J]. 光明中医, 2011, 26(2): 333-334.

[7] 梁华平, 张艳. 黄芪多糖调节创伤小鼠白介素2及白介素2受体基因表达的实验研究[J]. 中医药学报, 1995(3): 27-29.

[8] 陈慧英, 张苏玲, 刘文虎. 黄芪多糖对重组白介素_2激活LAK活性的调下作用[J]. 南京中医学院学报, 1994(6): 29-30.

分享
Top